To determine whether the endogenous p53 mutant can bind to the promoter of miR-130b, chromatin immunoprecipitation (ChIP) and qPCR analysis on HEC-1 cells was made, demonstrated that miR-130b is a direct target of p53 mutant in endometrial cancer (EC) cells. This evidence concerns the gene TP53 and endometrial cancer.